Boston Sci Expands Obsidio Correction to Include All GI Bleeding Embolization

Since the initial recall in Q124, the company has now updated its IFU barring the Obsidio from all GI bleeding embolizations after reports the aliquot technique resulted in high risk of bowel ischemia.